The SEC has implemented the initial intensive measures for securities public offering companies and listed companies that commission carbon footprint preparation reviewer in accordance with the Notification of the Office of the Securities and Exchange Commission No. Sor Mor. 18/2564 Re: Measures on Fee Deduction for Filing the Registration Statement for Securities Offering and the Annual Registration Statement for Companies Disclosing Greenhouse Gas Emission Data, dated 10 March 2021. The fee de...
personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling
%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue
order to accommodate business expansion. 3Q17 administrative expenses nevertheless increased merely 7% which was half of the 9-month period. It can imply that most of the increase was in the first half of
& vaccination as well as capacity expansion. OPD increased by 4 units and IPD increased by 22 units yoy. OPD income was driven by revenue per head while number of patients (not included outside check-up
operations for 2nd Quarter of 2017 decreased to 71.69%, while it was 74.38% for the 2nd Quarter of 2016. These resulted from the efficiency of medicine and medical supplies cost management, introducing an
rehabilitation services for patients with diabetes. Kasemrad International Hospital Rattanathibeth opened an Advanced Internal Medicine on the 2nd floor with a team of doctors and personnel who are specialized in
for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be transferred on share sale and purchase date from the seller’s connected
established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be